MVA-BN RSV: Phase I started

Bavarian Nordic began a single-blind, placebo-controlled, U.S. Phase I trial to evaluate 2 dose levels of MVA-BN RSV vaccine in 63 healthy volunteers. Volunteers ages 18-49 will receive both doses, w...